Immuneering Corp (IMRX)
1.98
+0.12
(+6.45%)
USD |
NASDAQ |
Nov 05, 16:00
1.98
0.00 (0.00%)
After-Hours: 19:06
Immuneering Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2020
--
Maximum
Dec 2020
--
Average
--
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| Singular Genomics Systems Inc | 0.0461 |
| Biomarin Pharmaceutical Inc | 0.1098 |
| Integra Lifesciences Holdings Corp | 1.190 |
| Eton Pharmaceuticals Inc | 0.346 |
| Tenon Medical Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 77.09M |
| Total Liabilities (Quarterly) | 10.78M |
| Shareholders Equity (Quarterly) | 66.31M |